Sino Medical Sciences Technology, Inc. (688108.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 15.75

From 52W high−16.92%

Volume8.70M

Market capCNY 7.37B

P/E (TTM)155.8x

P/S (TTM)11.6x

Div yield—

Key dataSep 18, 2026

Open

CNY 15.75

From 52W high

−16.92%

Volume

8.70M

Market cap

CNY 7.37B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

42.4x

P/E (TTM)

155.8x

RSI (14)

37.8

MomentumView details →

1D Return

−4.60%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

155.8x

EV/EBITDA

42.4x

EV/Sales

11.3x

P/S (TTM)

11.6x

P/B (TTM)

7.4x

ProfitabilityView details →

Gross Margin

68.37%

Net Margin

12.19%

EBITDA Margin

26.59%

ROE (TTM)

6.93%

ROA (TTM)

5.18%

Asset Turnover

0.42x

GrowthView details →

Revenue YoY

+20.44%

EPS YoY

+780.95%

FCF YoY

+115.99%

Revenue CAGR 3Y

+39.67%

EPS CAGR 3Y

+2650.00%

EBITDA YoY

—

MomentumView details →

1D Return

−4.60%

YTD Return

—

1Y Return

—

RSI (14)

37.8

vs 50D SMA

−7.22%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.13x

Current Ratio

2.54x

Quick Ratio

2.08x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

CNY 0.06

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

CNY 0.00

Avg Surprise (4Q)

—

Rev Surprise

−1.06%

Financials snapshotView financials →

Revenue (TTM)

564.29M

Net Income (TTM)

68.78M

Op. CF (TTM)

183.54M

Next earningsOct 26, 2026 →

Latest newsMore news →

China's National Medical Products Administration confirmed that Lantval, a sutureless aortic valve replacement system jointly developed by Cardio Health Medical and Fuwai Hospital, entered the special review procedure for innovative medical devices.11d ago

Shenzhen Sineuro Medical Technology Co., Ltd., a subsidiary of Sinomed, received a Class III medical device registration certificate from China's National Medical Products Administration for its delivery-type balloon dilation catheter, valid until August 30, 2031.19d ago

Similar companies

新华医疗600587.SH 万东医疗600055.SH Zylox-Tonbridge Medical Technology Co., Ltd.02190.HK 浩欧博688656.SH Bruker CorporationBRKR LifeTech Scientific Corporation01302.HK Find similar companies →

Latest newsMore news →

China's National Medical Products Administration confirmed that Lantval, a sutureless aortic valve replacement system jointly developed by Cardio Health Medical and Fuwai Hospital, entered the special review procedure for innovative medical devices.11d ago Shenzhen Sineuro Medical Technology Co., Ltd., a subsidiary of Sinomed, received a Class III medical device registration certificate from China's National Medical Products Administration for its delivery-type balloon dilation catheter, valid until August 30, 2031.19d ago